Celldex Therapeutics (CLDX) Q1 2017 Earnings

14MarConfirmed
Q2 2016
Aug 16
Q4 2016
Q1 2017
-5.55
-3.81
-2.06
-0.32

Details

Expected EPS
-5.55
Actual EPS
-4.5
Surprise EPS
1.05
Surprise Percent
+18.92%

Description

Celldex Therapeutics (CLDX) has reported earnings of -4.5 per share for Q1 2017.

0 Comments

Share your thoughts